Lecturer in Cardiovascular or Metabolic Neuroscience in London

Within the UCL Division of Biosciences, the Department of Neuroscience, Physiology and Pharmacology (NPP) is internationally renowned for its fundamental research that incorporates cellular, molecular and systems-based studies of neurotransmitter receptors and ion channels, neurophysiology, neural networks, and associated signalling pathways.

NPP seeks to appoint a new Lecturer (Research & Teaching) in Cardiovascular or Metabolic Neuroscience, to complement existing areas of expertise within CCMN, and further strengthen research and teaching for this translationally important area.

As a new Lecturer, you will:

• Establish an independent and internationally competitive research programme in cardiometabolic neuroscience, with opportunities for substantial grant funding and access to UCL's world‐class infrastructure.
• Inspire the next generation of scientists through innovative teaching at undergraduate and postgraduate levels, particularly by advancing our curriculum in cardiovascular and/or metabolic physiology, pharmacology and neuroscience.
• Mentor and supervise research students, fostering the development of future leaders in the field while building your own research group.
• Forge interdisciplinary collaborations within CCMN and across UCL's wider network of metabolism and neuroscience researchers.
• Contribute to departmental initiatives, knowledge exchange activities, and public engagement.

This appointment is subject to UCL Terms and Conditions of Service for Academic Staff. As part of your application, you are required to submit as a cover letter, a two-page Vision Statement outlining your innovative ideas for advancing Cardiometabolic Neuroscience in both research and teaching contexts. This statement should articulate your unique perspective on the field's future and how your work would contribute to its development at UCL.

We are seeking applicants with expertise in Cardiometabolic Neuroscience, which is defined broadly in this context. It encompasses the following fields of study: central nervous control of circulation, control of eating behaviour and metabolism, and studies of autonomic mechanisms which contribute to the development of cardiovascular, metabolic and/or neurodegenerative disease. The approaches to study these could include (but are not limited to) computational modelling or bioinformatics, metabolomics/genomics/lipidomics, pre-clinical studies using experimental animals, and/or clinical experimentations.

The recruit's research profile will ideally align with one or more of the Faculty of Life Sciences' strategic priorities: Computational Healthcare & Artificial Intelligence; Engineering Biology; and Disease Interception. Relevant approaches which align with these priorities could include deep learning-based analyses of behaviour, physiology and/or neural activity; predictive AI-based approaches for metabolic phenotypes or drug targets; modelling approaches to reduce and/or refine the use of animal models in cardiometabolic research; design/validation of novel therapeutic peptides/biologics; identification of strategies for early intervention to reduce cardiometabolic disease risks.

UCL has a strong track record of translating basic science discoveries into spinout companies and clinical practice, and this is a priority for the future, in accordance with UKRI funding priorities. We therefore particularly welcome applicants with a compelling vision for the translation of their research into preventative and/or therapeutic strategies to improve cardiometabolic health.